Cadrenal Therapeutics (CVKD) vs Kairos Pharma (KAPA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($3.2 million vs $2.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVKD | KAPA |
|---|---|---|
| Share price | $0.9101 | $0.8103 |
| Market cap | $3.25M | $2.74M |
| 1-day change | -2.10% | -15.55% |
| EPS (TTM) | $-4.91 | $-1.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $9.24 |
| 52-week low | $0.85 | $0.7827 |
| Distance from 52-week high | -93.72% | -91.23% |
| Analyst consensus | none | none |
| Avg. price target upside | +1438.29% | +5947.14% |
| Average volume | 458.82K | 602.89K |
| Shares outstanding | 3.57M | 3.39M |
| Employees | 5 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About Kairos Pharma
KAPA stock →Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
CVKD vs KAPA FAQ
Which is bigger, Cadrenal Therapeutics or Kairos Pharma?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $3.25M compared with $2.74M for Kairos Pharma (KAPA).
Are Cadrenal Therapeutics and Kairos Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.